Clinical Trial Update: Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases [Phase 2]

View source ↗

Summary

Phase 2 trial assessing megadose CD34+ selected progenitor cell transplantation in patients with advanced hematologic malignancies (leukemia and lymphoma); the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Megadose CD34+ Selected Progenitor Cells (CD34+ selected progenitor cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-08-07